Ads
related to: immunology
Search results
Biogen in up to $1.8 Billion Deal as Rare Diseases Take Center Stage
US News & World Report· 7 days agoHuman Immunology's (HI-Bio) felzartamab has completed mid-stage studies for a type of kidney disease called primary membranous nephropathy, and in patients with a disease ...
Biogen enters deal to acquire HI-Bio for $1.8bn
Pharmaceutical Technology via Yahoo Finance· 6 days agoBiogen has signed a definitive agreement to acquire clinical-stage biotechnology company Human Immunology Biosciences (HI-Bio) in a $1.8bn deal. The...
Bird flu in Florida? Safe to consume chicken and milk? How the outbreak can affect you
Miami Herald via Yahoo News· 22 hours agoHarry Feinstone department of molecular microbiology and immunology at the Johns Hopkins Bloomberg...
Greater Austin Allergy clinic to relocate within Bee Cave
Community Impact· 10 hours agoThe Austin-based business specializes in treatment for nasal and sinus, lung, skin and food...
Biogen in up to $1.8 billion deal as rare diseases take center stage
Reuters via AOL· 7 days agoHuman Immunology's (HI-Bio) felzartamab has completed mid-stage studies for a type of kidney disease...
Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology
FierceBiotech· 7 days agoBiogen is placing a $1.15 billion bet on Chris Viehbacher’s diversification vision. The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio ...
Biogen to buy Peninsula startup developing a drug for kidney disease for $1.2 billion - San...
The Business Journals· 7 days agoBiogen Inc. is shelling out $1.15 billion upfront to buy HI-Bio, a South San Francisco immunology...
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding...
KOIN News 6 Portland· 4 days agoScinai Immunotherapeutics Ltd. (the "Company") (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and ...
Feeding peanuts to young children can reduce allergy risk: Study
The Hill via Yahoo News· 12 hours agoChildren who consume peanut products in the first five years of their lives are less likely to...
Biogen to Buy Human Immunology Biosciences for Up to $1.8 Bln
Market Watch· 7 days agoBiogen is buying the privately-held biotechnology company Human Immunology Biosciences for as much as $1.8 billion in a move to expand its immunology portfolio ...
